Clinical Decision Support System Market Size, Share, Growth Analysis, By Product(Standalone CDSS, Integrated CPOE with CDSS, Integrated E.H.R. with CDSS, Integrated CDSS with CPOE & E.H.R.), By Application(Drug-drug Interactions, Drug Allergy Alerts, Clinical Reminders, Clinical Guidelines), By Deployment Mode(Web-based Systems, Cloud-based Systems, On-premise Systems), By Component(Hardware, Software, Services), By Region - Industry Forecast 2024-2031

Global Clinical Decision Support System Market size was valued at USD 2.78 billion in 2022 and is poised to grow from USD 3.01 billion in 2023 to USD 5.61 billion by 2031, growing at a CAGR of 8.10% in the forecast period (2024-2031).

One of the primary factors driving the market's growth is the increasing demand for trustworthy technical solutions that are integrated into high-quality care. The market is expanding as a result of more hospitals and healthcare facilities implementing information systems, as well as beneficial global government efforts. Authorities like the FDA impose rigorous regulations on clinical decision support systems. Platforms that have been introduced or are still in the development stage must therefore meet pertinent standards stipulated by the FDA and CE Mark. Competitors must also ensure that information technology and cyber regulations are not broken in order to ensure the integrity of their products.

Initiatives have been done by CDSS vendors and groups to assist stop the epidemic. As it demonstrated how healthcare teams can stay up to date on the newest COVID information and intelligence, helping to increase the quality of the care they give, CDSS has grown into a crucial weapon in the fight against COVID-19. In individuals with a moderate to high chance of COVID-19, the Infectious Diseases Society of America recommended repeating a COVID-19 test. There was, however, little guidance as to what circumstances made a patient more or less likely to get the infection. At Massachusetts General Hospital, an infectious disease team was on duty constantly. Consequently, focused efforts resulted in the creation of a CDS tool known as COvid Risk cALculator (CORAL). The EHR has the tool integrated into it. This should have a favourable effect on market expansion. Additionally, CORAL's outpatient version was unveiled in October 2021. The only algorithm that has been included into ordinary, prospective physician workflow through an EHR CDSS is CORAL, which has maintained its exclusivity.

The COVID-19 outbreak has put medical practices of all sizes under a great deal of stress, and healthcare facilities around the world are being overrun by the large number of patients who are visiting them each day. The emergence of this pandemic has increased demand for precise diagnostic and therapeutic tools in numerous nations around the world. Clinical decision support systems have proven to be helpful in this regard because they enable healthcare professionals and organisations to monitor patients using a variety of tools, like home blood pressure monitors and pulse oximeters. In addition, the rapid global spread of this disease has led to a shortage of hospital beds and medical personnel. This has increased the need for connected medical devices for monitoring vital signs.

Additionally, due to the pandemic, there was a greater requirement for social distance between doctors and patients, which boosted the demand for CDSS solutions and a quick and accurate transmission of patient health records. Many market participants have included COVID-19-related functionality into their current EHRs, which are freely accessible to users.

US Clinical Decision Support System Market is poised to grow at a sustainable CAGR for the next forecast year.